Low Na ؉ diet inhibits Na ؉ and water transport response to vasopressin in rat cortical collecting duct.
Our previous experiments with the rat cortical collecting duct (CCD) have shown that arginine vasopressin (AVP) produces a marked stimulation of Na ϩ reabsorption that is synergistic to the effect of pharmacological concentrations of the mineralocorticoid deoxycorticosterone (DOC) [1, 2] . We have subsequently demonstrated that this synergism also occurs when the mineralocorticoid used is aldosterone at concentrations corresponding to what is observed in vivo with only moderate salt depletion [3] . However, we observed that the AVP concentration required to achieve a maximal synergistic effect was greater with the aldosterone treatment compared to the DOC treatment, although in both instances significant stimulation of Na ϩ transport was produced at physiologically relevant concentrations of AVP (5 to 40 pM).
The effects of both aldosterone and DOC on the transport capacity of the rat CCD may relate to the direct effect of the mineralocorticoid and/or to changes in the delivery of Na ϩ to the distal nephron. As shown in the classic study of Schwartz and Burg [4] , Na ϩ and K ϩ transport in the rabbit CCD measured in vitro are altered by in vivo dietary manipulation. For example, when plasma aldosterone was reduced to zero by a high-Na ϩ /low-K ϩ diet, Na ϩ reabsorption and K ϩ secretion were reduced to 50% of control levels. When plasma aldosterone was increased 18-fold by a low-salt diet and furosemide treatment, Na ϩ reabsorption and K ϩ secretion increased about two-fold [4] . These and other observations showed that the rate of Na ϩ and K ϩ transport in vitro was closely correlated with the plasma aldosterone concentration in vivo despite the fact that no mineralocorticoid was present in the in vitro solutions in which the CCD were studied [4] .
In other studies, it has been shown that the rate of Na ϩ delivery and/or the intracellular Na ϩ concentration may also alter transport rates in the distal tubule and collecting duct independent of changes in aldosterone. Stanton and Kaissling [5, 6] demonstrated that increasing Na ϩ delivery to the distal nephron by furosemide and a high-salt intake increased the volume and basolateral membrane surface area of DCT cells, connecting tubule cells, and principal cells of the collecting ducts. In these and other studies [7] the morphologicial changes were accompanied by an increased capacity of the distal tubule to reabsorb Na ϩ and secrete K ϩ . These changes occurred despite the fact that the plasma aldosterone concentration was maintained constant by prior adrenalectomy and corticoid replacement by osmotic minipump. Similarly, increased in vivo Na ϩ delivery to the distal nephron increased Na ϩ transport rates measured in the isolated perfused rabbit CCD [8, 9] . The interpretation of these studies is that increased Na ϩ transport in response to increased Na ϩ delivery to the distal nephron segments results in a "hypertrophy" of the cells and the transporters involved [6, 7, 10] .
Examining our previous studies demonstrating the synergism between physiologic aldosterone and AVP concentrations [3] , there could be two reasons for the increased transport capacity of the CCD. Because the rats in these studies were maintained on a standard 1% NaCl diet, it would be expected that distal Na ϩ delivery would be increased due to the mineralocorticoid escape phenomenon. Thus, not only might aldosterone have increased the transport capacity of the CCD through a direct action on the principal cells, but alternatively or in addition, increased Na ϩ delivery to the CCD might have produced the increase. Thus, the situation in our previous experiments, that is, increased aldosterone with a normal Na ϩ intake and no extrarenal Na ϩ loss, was not truly physiological.
For this reason we undertook experiments to produce a more typical setting in which the physiological interplay of mineralocorticoids and AVP could be examined. We chose to study CCD from rats that had been treated with a single dose of furosemide and then maintained on a low-salt diet (0.3%) as a model in which plasma aldosterone concentrations would be moderately but not severely elevated due to mild volume depletion. The results reinforced the importance of salt delivery in the response to mineralocorticoid, and also indicated the presence of more complex effects on both the osmotic water permeability and Na ϩ transport response to AVP.
METHODS
Cortical collecting ducts were dissected from outbred Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN, USA). When received, the rats weighed 40 to 50 g. Two days after receipt the rats were treated according to one of three protocols:
(1) Low-salt group. Administration of a single 2 mg dose of furosemide intramuscularly, followed by maintenance on a diet containing nominally 0.3% NaCl (Diet #100077 from Dyets, Inc., Bethlehem, PA, USA; based on AIN-76 pelleted diet; measured in our laboratory as containing 0.37% NaCl).
(2) DOC ϩ low salt group. At the same time the rats were given furosemide as in the previous protocol, they were also anesthetized by brief exposure to CO 2 , and a 2.5 mg pellet of deoxycorticosterone (DOC; Innovative Research of America, Toledo, OH, USA) was implanted subcutaneously in the interscapular region with a trochar designed for this purpose. These rats were then maintained on the 0.3% NaCl diet for four to nine days before use.
(3) DOC ϩ standard diet group. Implantation of a 2.5 mg DOC pellet as above, without furosemide, was followed by maintenance on a standard diet of pelleted rat chow (Prolab RMH100; Agway Inc., Syracuse, NY, USA; containing 0.99% NaCl as measured in our laboratory) and tap water, both ad libitum.
Rats in all groups weighed 80 to 110 g at the time of tubule dissection.
In rats maintained on the low-salt protocol (without DOC), serum samples were collected at the time of the experiment and were analyzed for aldosterone by radioimmunoassay using the Coat-A-Count kit (Diagnostic Products Corp., Los Angeles, CA, USA) according to the accompanying directions. The average aldosterone concentration was 0.73 Ϯ 0.12 nM (26.4 Ϯ 4.4 ng/dl; N ϭ 17). This is significantly higher than aldosterone levels typically measured in control animals of approximately the same size and on the same diet, that is, 0.11 to 0.19 nM (4 to 7 ng/dl) [11] , but much less than values observed with severe chronic sodium depletion, which have been reported to be as high as 13.9 nM (500 ng/dl) with a completely salt-free paste diet [11] [12] [13] . Thus, the plasma aldosterone levels could be regarded as moderately elevated in comparison with controls on a standard diet.
The techniques used to dissect and perfuse CCD from rat nephrons have been previously described in detail [1, 2, 14] . In all experiments, the perfusate solution composition and pH approximated that of fluid in the early distal tubule [15] , and contained (in mM): 88 NaCl, 5 KCl, 2 sodium phosphate (final pH 6.6), 1.5 CaCl 2 , 0.5 MgCl 2 , and 50 urea. The solution was equilibrated with 95% O 2 /5% CO 2 at 38°C, and the measured osmolality was 200 to 230 mOsm/kg H 2 O. The bathing solution approximated an ultrafiltrate of rat serum and contained (in mM): 122 NaCl, 25 NaHCO 3 , 5 KCl, 5 sodium acetate, 2 sodium phosphate (final pH 7.4), 1.5 CaCl 2 , 0.5 MgCl 2 , 8 glucose, 4 L-alanine, and 6 urea. The measured osmolality averaged 314.7 Ϯ 5.7 (standard deviation; SD) mOsm/kg H 2 O, and the pH was adjusted to 7.40 when equilibrated with a 95%/5% mixture of O 2 and CO 2 at 38°C.
The experiments were carried out at 38°C, and were designed so that measurements of J Na , P f , and V T could be performed in the same experiment. The volume marker, [methoxy-3 H]-inulin, was added to the perfusate at ϳ50 Ci/ml to determine the perfusion rate, and the leakage of perfusate was measured from the rate of appearance of 3 H in the bathing solution. Only experiments with 3 H leak rates less than 1% of that perfused were included in the reported data. The perfusion rate was 10 to 15 nl/min.
Measurement of Na ؉ and water transport parameters
The rate of volume absorption was calculated and normalized by the tubule length as described previously [1, 14, 16] . The length of the tubule segment was measured at the end of an experiment using an ocular micrometer. P f was calculated from the observed water flow and the measured osmolalities of the initial perfusate solution and the bathing solution [1, 14, 16] . J Na was determined by adding ϳ50 Ci/ml 22 Na ϩ to the perfusate solution and measuring the rate of appearance of 22 Na ϩ in the bathing solution, as described previously [1, 2, 14, 16] . In all experiments V T was measured continuously between 0.9% NaCl-4% agarose bridges placed in the perfusate and bathing solutions, and displayed on a strip chart recorder. For convenience, V T values will be discussed in terms of their absolute value. Thus, for example, a hyperpolarization of the usually lumen-negative V T is referred to as an increase in V T .
Experimental protocols
After dissection in chilled bathing solution, CCD were mounted between the perfusion and collection pipettes, and the perfusion solution was changed to one containing the 3 H-methoxyinulin and 22 Na ϩ . The temperature was raised from room temperature to 38°C over a 10 to 15 minute period. After a stable V T had been achieved, samples of the collected bath and lumen perfusates were taken at 10 minutes intervals.
The protocols were the same with each group of rats. There was an initial control period in which no drugs were added. Five or six 10-minute collections of the bathing and perfusing solutions were made for determination of J Na and P f . AVP was then added at 200 pM to the bathing solution and five collection periods followed. In the third period a potential inhibitor of J Na and P f was added to the bathing solution or to the luminal perfusate, followed by five collection periods. In some protocols there was a final period of five collections in which the inhibitor was removed and only AVP remained in the bathing solution. In each period parameter values in the last three collections were averaged to give a value for that period. Individual experiment averages were in turn averaged to give a mean value for the protocol.
Sources of biochemicals
Synthetic arginine vasopressin, hydrochlorothiazide (HCTZ), L-(-)-epinephrine, yohimbine and ouabain were obtained from Sigma Chemical Co. (St. Louis, MO, USA). A stock solution of 200 M AVP in water was prepared weekly, and was added to the bathing solution to give a final concentration of 200 pM. HCTZ was prepared directly in the luminal perfusate solution at 100 M. A fresh 1 mM stock solution of epinephrine in water was made immediately before each experiment in which it was used. Aliquots of a stock solution of 1 mM yohimbine in water were frozen for use in individual experiments. Ouabain was frozen in aliquots of a 20 mM stock solution in water. Benzamil was a gift from Dr. T.R. Kleyman (Univ. of Pennsylvania); it was prepared as a 1 mM stock solution in dimethylsulfoxide. The isotopic tracers [methoxy-3 H]-inulin and 22 Na ϩ were obtained from DuPont-New England Nuclear Products (Boston, MA, USA).
Data analysis and statistics
Average parameter values were calculated for each period in each experiment. These averages were then used to compute an overall average parameter value (Ϯ SE) for all experiments in each protocol. Treatment effects among experimental periods within the same protocol were tested for significance (P Ͻ 0.05) by ANOVA (SuperANOVA software; Abacus Concepts, Berkeley, CA, USA) with experiments treated as blocks, using the Scheffé F-ratio test. Comparisons between different groups of animals were made by nonpaired t-test with significance at P Ͻ 0.05.
RESULTS
In our first series of experiments we examined the effects of salt depletion on transport parameters in CCD from the low-salt group of rats. In 15 experiments, J Na in the control Cortical collecting ducts (CCD) from three groups of rats were examined: (A) rats that had been treated with furosemide and kept on a low-salt diet (N ϭ 15), (B) rats that had been treated with furosemide, implanted with a 2.5 mg deoxycorticosterone (DOC) pellet, and kept on the low-salt diet (N ϭ 11), and (C) rats that were implanted with a DOC pellet and were kept on a standard diet (Std. Diet; N ϭ 7 1A ). P f was not significantly different from zero in the control period (Ϫ3 Ϯ 34 m/second) but rose significantly (P Ͻ 0.001) to 418 Ϯ 56 m/second after addition of 200 pM AVP ( Fig. 2A) .
The 15 CCD examined in the low-salt group were divided into three subgroups in which the effects of epinephrine, ouabain, and HCTZ were examined as shown in Table 1 . Addition of either 100 nM epinephrine or 100 M ouabain to the bathing solution, which still contained AVP, significantly inhibited J Na and V T ; however, epinephrine inhibited P f whereas ouabain had no effect. The effects of epinephrine were reversed by 1 M of the ␣ 2 -adrenoceptor antagonist yohimbine. Ouabain removal reversed its effect on V T . The reversibility of the ouabain effects on J Na and P f were not examined because the final period was only maintained for five minutes, which was sufficient to demonstrate the reversal of V T . Luminal HCTZ had no significant effect on P f , J Na , or V T .
Because all parameter values in the low-salt group were significantly less than had been anticipated from the increased plasma aldosterone concentration, we examined CCD from rats receiving furosemide and the low-salt diet, but which were also implanted with a DOC pellet ( Table 2; Figs. 1B and 2B). J Na in the control period was 39.0 Ϯ 4.9 and rose significantly (P Ͻ 0.001) to 103.4 Ϯ 12.7 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 upon the addition of AVP to the bathing solution ( Fig. 1B) . Nonpaired t-tests revealed that J Na for the DOC ϩ low-salt group was higher in both the control period (P ϭ 0.004) and in the AVP period (P Ͻ 0.001) compared with the low-salt group. However, V T and P f values were not significantly different between the two groups in either period. The further addition of 100 nM epinephrine in the third period significantly inhibited all three parameters, and the effect was reversed by 1 M yohimbine ( Table 2) .
CCD from rats treated with furosemide and low-salt, either with or without DOC treatment, had lower P f values in the presence of AVP than observed in previous studies with rats on a standard diet. To confirm this we conducted a third set of experiments with CCD from rats in the DOC ϩ standard diet group, which repeated previous protocols, such as, [1] [2] [3] 17] . As shown in Figure 1C and Table 3 , J Na
Fig. 2. Effect of diet and mineralocorticoid treatment on osmotic water permeability (P f ).
Cortical collecting ducts (CCD) from three groups of rats were examined: (A) rats that had been treated with furosemide and kept on a low-salt diet (N ϭ 15), (B) rats that had been treated with furosemide, implanted with a 2.5 mg deoxycorticosterone (DOC) pellet, and kept on the low-salt diet (N ϭ 11), and (C) rats that were implanted with a DOC pellet and were kept on a standard diet (Std. Diet; N ϭ 7). Results from individual experiments are shown by the dashed lines, and the average for all experiments in a group by the solid lines. See text for statistical comparisons. Table 1 . Osmotic water permeability (P f ), transepithelial voltage (V T ), and lumen-to-bath 22 Na ϩ flux (J Na ) in cortical colleting ducts (CCD) from rats treated with furosemide and the low-salt diet All CCD were from rats that had been treated with furosemide and maintained on a low salt diet as described in the Methods section. In the first group of experiments (N ϭ 6), 100 nM epinephrine (Epi) was added to the bathing solution in the third period, followed by the further addition of 1 M yohimbine (Yoh) to the bathing solution in the last period. In the second group (N ϭ 4), 100 M ouabain was added to the bathing solution in the third period, and removed in the fourth period. (Only V T was measured in the final period.) In the third group of experiments (N ϭ 5), 100 M hydrochlorothiazide (HCTZ) was added to the luminal perfusate in the third period. The combined results from the three groups for J Na and P f in the control and AVP periods are shown in Figures 1A and 2A . In all three groups, parameter measurements were made first in a control period, followed by a period in which 200 pM AVP was added to the bathing solution. a Significantly different from control period, b significantly different from preceding period, by ANOVA Schafer and Chen: Low Na ϩ diet and AVP action in CCD and V T in the control and AVP periods in this group were not significantly different from the results in the DOC ϩ low-salt group, and ouabain reversibly inhibited both parameters ( Fig. 3) . Upon the addition of AVP, P f values, while duplicating those observed in previous DOC ϩ standard diet experiments [1] [2] [3] 17] , were significantly higher than seen in either the low-salt (P Ͻ 0.002) or the DOC ϩ low salt (P ϭ 0.02) groups.
DISCUSSION
We used volume depletion produced by a single injection of furosemide followed by maintenance on a low Na ϩ diet in order to examine the effects of physiologically relevant plasma concentrations of aldosterone on Na ϩ transport and its response to AVP in the rat CCD. Our objective in using this regimen was to produce a significant elevation of the plasma aldosterone concentration, without producing severe volume depletion that could have had less specific effects. Thus, the measured aldosterone concentration of ϳ0.7 nM for the seventeen rats used in the low-salt protocol is significantly greater than that reported for rats on a standard diet [11] [12] [13] , but it is at the lower end of the observed 0.6 to 4.3 nM range in rats on a low-Na ϩ or Na ϩ -free diet [11] [12] [13] and also in the range produced by osmotic minipumps implanted in rats and delivering aldosterone at rates calculated to mimic physiologically elevated aldosterone secretion [18 -20] .
When CCD from our low-salt group were examined by in vivo perfusion, we were surprised to find that J Na was not significantly different from that observed in our previous studies in CCD from rats without mineralocorticoid treatment and maintained on a standard diet. From records kept in our laboratory of previous experiments 2 , the average J Na in CCD from rats on a standard diet with no mineralocorticoid treatment was 38.1 Ϯ 3.3 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 (N ϭ 24) in the absence of AVP and 60.7 Ϯ 6.0 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 (N ϭ 24) with 200 pM AVP. These values are not significantly different from the respective averages of 22.1 Ϯ 12.4 and 48.6 Ϯ 16.0 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 obtained in the present twelve experiments with CCD from low-salt rats ( Table 1 ). In the absence of AVP, V T in the low-salt rats was not significantly different from our previous observations in CCD from either DOC-treated or untreated N ϭ 11) were from rats that had been treated in vivo with DOC and furosemide, and maintained on a low salt diet as described in the Methods section. Parameter measurements were made first in a control period, followed by a period in which 200 pM AVP was added to the bathing solution.
a Significantly different from control period, b significantly different from preceding period; by ANOVA. Table 3 . Osmotic water permeability (P f ), transepithelial voltage (V T ), and lumen-to-bath 22 Na ϩ flux (J Na ) in cortical collecting ducts (CCD) from rats treated with deoxycorticosterone (DOC) and a 1% NaCl diet All CCD (N ϭ 7) were from rats that had been implanted with a DOC pellet and maintained on a standard salt diet as described in the Methods section. Parameter measurements were made first in a control period, followed by 200 pM AVP added to the bathing solution. Ouabain (100 M) was added to the bathing solution in the third period, and removed in the fourth period. a Significantly different from control period, b significantly different from preceding period, by ANOVA rats on a standard diet. On the other hand, the AVPdependent V T , which usually parallels J Na , averaged Ϫ17.3 Ϯ 2.2 mV. While this was significantly higher than our historical average in AVP-treated CCD from rats on a standard diet with no mineralocorticoid treatment (Ϫ8.2 Ϯ 1.0 mV), it was not significantly different from our historical average of Ϫ21.8 Ϯ 0.7 mV (N ϭ 164) in AVP-treated CCD from DOC-treated rats on a standard diet.
Another intriguing finding was that P f rose much less with AVP treatment than observed previously in CCD from animals on a standard diet. In the low-salt rats P f with AVP averaged 418 Ϯ 208, which was significantly lower than our historical averages of AVP-dependent P f in CCD from untreated rats (1009 Ϯ 99 m/second, N ϭ 33, P Ͻ 0.01) and DOC-treated rats (968 Ϯ 43, N ϭ 96, P Ͻ 0.01).
To summarize these comparisons: the J Na values in the low-salt group with or without AVP were not significantly different from values expected if the rats had been on a standard diet with no mineralocorticoid treatment, but the V T values after AVP treatment were at levels that we had observed previously only in CCD from DOC-treated rats on a standard 1% NaCl diet. The dissociation of J Na and V T suggests that not only the active component of Na ϩ reabsorption is inhibited, but that there may also be a decreased passive backflux through the paracellular pathway. An increase in the paracellular resistance would explain the persistence of a relatively high lumen-negative V T despite diminished active transcellular transport. Structural alteration of the CCD is also suggested by the fact that AVP-dependent P f in the low-salt group was significantly lower than observed in CCD from rats on a standard diet with or without DOC treatment.
We further examined CCD in the low-salt group by attempting to inhibit the transport response to AVP using epinephrine, ouabain, and HCTZ. We have previously demonstrated that 100 nM epinephrine, acting through an ␣ 2 -adrenoceptor, almost completely inhibits P f , J Na , and V T in CCD from DOC-treated rats on a standard diet [17] . We found the same effects in these experiments ( Table 1) although all of the parameters remained significantly higher than control levels. Further addition of the ␣ 2adrenoceptor antagonist yohimbine reversed the effect of the epinephrine. Although we previously demonstrated that 100 M ouabain reduced V T to nearly zero [21] , its effect on J Na and P f had not previously been reported. As expected, this Na,K-ATPase inhibitor reduced AVP-dependent J Na and V T to values not significantly different from the control, but had no effect on P f . The effect on V T was reversible; the reversibility of the effect on J Na was not examined in this group (but see Table 3 ).
Although immunohistochemistry [22] and our previous data [23] provide no evidence for the presence of the thiazide-sensitive NaCl cotransporter in the CCD, we tested the effect of HCTZ because of previous suggestions that this cotransporter might be up-regulated by a low-salt diet [19, 23] . However, we found no inhibition of J Na when HCTZ was added to the luminal perfusate at 100 M (Table 1) .
We next examined if the aldosterone levels produced by the salt depletion might be limiting to the transport response to AVP. In these experiments ( Table 2) we used the same low-salt protocol but also implanted the rats with a 2.5 mg pellet of DOC (the DOC ϩ low salt group). J Na was 103 Ϯ 12 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 in the presence of AVP, which is significantly lower than our historical average of 154.0 Ϯ 4.0 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 obtained in 161 experiments with AVP-treated CCD from DOC-treated rats on a standard diet. However, it should be noted that average values of J Na in individual groups that comprise this historical average have been as low as 107 Ϯ 17 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 (N ϭ 4) [3] , which is not significantly different from the value reported in Table 2 . V T values in the DOC ϩ low-salt group were not significantly different from historical averages in CCD from DOC-treated rats on a standard diet, but the average AVP-dependent P f ( Table 2) was again lower (P Ͻ 0.001) than the historical average P f of 968 Ϯ 43 m/s (N ϭ 96) observed in CCD from DOCtreated rats on a standard diet.
To be sure that we could reproduce our previous results, which have been used for comparison in the discussion above, we examined CCD from DOC-treated rats that had been maintained on the standard 1% NaCl diet. One of the same experimenters who conducted the majority of the first two series of experiments conducted these additional experiments contemporaneously with the experiments reported in Table 1 . The rats were of the same size and age. As shown in Table 3 , J Na was significantly higher in this group than in the low-salt group (Table 1 ; P Ͻ 0.001); however, although the mean was greater than in the DOC ϩ low-salt group (Table 2) , the difference was not statistically significant.
The failure to observe a significant stimulation of J Na in the low-salt protocol could be due to the fact that the plasma aldosterone concentrations reached were much lower than in other studies [4] in which a Na ϩ -free diet or significant volume depletion were used to elevate plasma aldosterone. This explanation is reinforced by the fact that administration of a pharmacological dose of DOC combined with the low-salt diet (DOC ϩ low-salt protocol) resulted in a significantly higher J Na (Table 2 ). However, administration of higher levels of mineralocorticoid might still deliver an increased salt load to the CCD by a "relative" DOC-escape despite the low salt diet. Also, in a previous study from our laboratory in which the plasma aldosterone concentration in rats on a standard salt diet was elevated by implantation of a 1 mg aldosterone pellet, there was significant stimulation of the AVP-dependent J Na [3] . In those studies the average plasma aldosterone concentration was 0.51 Ϯ 0.07 nM, which is not significantly different from the level in the present low-salt protocol, yet AVP increased J Na from 33.6 Ϯ 5.0 to 94.9 Ϯ 14.1 (unpublished averages from [3] ), which is significantly higher than observed in the present protocol (P Ͻ 0.01). Furthermore, although the low-salt protocol did not elevate J Na , it did increase AVP-dependent V T to the same levels as observed in the DOC ϩ low-salt and DOC ϩ standard diet protocols (Tables 2 and 3) , and in previous studies in which aldosterone was given in combination with a standard diet [3] . Thus, the low-salt protocol had a definite effect on the transport properties of the CCD, decreasing the AVPdependent P f and markedly augmenting AVP-dependent V T , despite its failure to augment the response of J Na to AVP.
Consequently, we favor the view that the failure of the low-salt protocol to significantly enhance the response of J Na to AVP was due to a decrease in the in vivo NaCl delivery to the CCD rather than to the lower level of mineralocorticoid. Physiologic levels of aldosterone have been shown to increase principal cell volume and basolateral membrane surface area in the rat CCD, but the effect was prevented when the animals were kept on a low-Na ϩ diet despite the fact that the plasma aldosterone concentration was maintained in the high physiologic range by osmotic minipump [20] . Both mineralocorticoid treatment and increased distal Na ϩ load are correlated with increased Na,K-ATPase activity in rat and rabbit CCD, but not if Na ϩ entry into the principal cells is prevented by amiloride or a low luminal Na ϩ concentration [24 -27] .
More recent data indicate that increased salt delivery to the distal nephron increases DNA synthesis in the cortical distal tubule segments, which has been interpreted to indicate increased cell proliferation [28] . However, as shown by Barlet-Bas et al [24] , the response to increased Na ϩ delivery or intracellular concentration is not just dependent on gene activation. In their studies, when Na ϩ entry into isolated rat CCD was increased by nystatin for two to three hours, Na,K-ATPase activity increased markedly, and this effect was prevented when Na ϩ was removed from the bathing solution.
In our studies it would be expected that the initial volume depletion produced by the single injection of furosemide followed by the low Na ϩ diet would have significantly reduced distal Na ϩ delivery. Although Ellison, Velásquez and Wright [7] , using free flow micropuncture, did not observe a statistically significant reduction of NaCl delivery to the early distal tubule in rats on a salt restricted diet, because of the variability in these measurements a change of less than 25% could not have been discerned, and they had not used furosemide to produce an initial volume depletion as we had. However, in their studies Ellison et al [7] did observe that volume flow to the early distal tubule was significantly reduced by a low salt diet.
The reduced volume flow to the CCD in salt-depleted rats may also be responsible for the reduced P f in response to AVP observed in both the low-salt and DOC ϩ low-salt protocols. [ We have previously shown that osmotic water flow and Na ϩ reabsorption are not directly coupled [1] , that is, the reflection coefficient of Na ϩ appears to be 1.0. This lack of coupling is confirmed in the present experiments (Tables 1 and 3 ) by the lack of any effect of ouabain on P f despite its inhibition of J Na .] As demonstrated previously [29] , an osmotic water permeability of 300 to 600 m/ second is more than adequate to allow osmotic equilibration between the dilute luminal fluid in the distal nephron and the isotonic cortex within the length of the CCD. Thus, the very high water permeability of the AVP-treated rat CCD on a standard diet could allow this segment to operate as an isosmotic volume reabsorber to maximize salt retention and negative free water clearance [29] . However, this function of the CCD would not be compromised by a lower P f response to AVP in the low-salt rats because of decreased fluid delivery and increased Na ϩ reabsorption in the distal tubule [7] .
If one also postulates that reduced Na ϩ delivery to the CCD was responsible for the lack of a significant effect of aldosterone on J Na , there must have been a concomitant increase in paracellular resistance that would account for the increase in V T . Alternatively, in the presence of decreased Na ϩ delivery AVP might still be acting to depolarize the luminal membrane by increased Na ϩ channel activity but transport would be limited by reduced Na,K-ATPase activity. Given the results of studies showing that Na,K-ATPase activity is stimulated by increased intracellular Na ϩ [26, 27] , the latter explanation seems less plausible.
In summary, the low-salt experiments demonstrate that maximal rates of active Na ϩ transport are achieved in the rat CCD only when both mineralocorticoid and AVP are present, and there is normal or elevated delivery of Na ϩ to the CCD. The diminished J Na response to AVP in the low-salt rats may reflect increased degradation and/or decreased synthesis of the transporters involved, a "disuse atrophy" so to speak, or it may be a function of the relative plasma mineralocorticoid concentration achieved. These observations also have important implications for the design of other studies in the CCD. Many investigators use a low-salt diet to elevate the activity of Na ϩ channels to be studied by patch clamping and other methods. Our results suggest that Na ϩ channel activity would be maximized by in vivo DOC administration in combination with a standard salt diet.
